Biogen, Inc.

( )
BIIB PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
REGNRegeneron Pharmaceuticals, Inc. -2.66%567.042.7%$651.45m
GILDGilead Sciences, Inc. -2.15%58.721.0%$577.62m
AMGNAmgen, Inc. -3.17%216.381.3%$567.02m
VRTXVertex Pharmaceuticals, Inc. -1.81%208.341.9%$534.17m
MRNAModerna, Inc. -6.98%65.740.0%$415.50m
ILMNIllumina, Inc. -3.75%309.693.5%$397.23m
EXASEXACT Sciences Corp. -2.75%127.5220.7%$297.60m
ALXNAlexion Pharmaceuticals, Inc. -4.29%114.852.0%$259.81m
BIIBBiogen, Inc. -4.32%244.261.7%$251.09m
NVAXNovavax, Inc. -9.22%81.3396.5%$238.36m
BNTXBioNTech SE -7.64%77.540.0%$198.15m
SRRKScholar Rock Holding Corp. 44.67%43.430.0%$174.98m
SGENSeagen Inc. -1.05%194.856.0%$144.96m
SRNESorrento Therapeutics, Inc. -8.04%7.091.4%$135.51m
CRSPCRISPR Therapeutics AG -3.48%94.710.6%$123.39m

Company Profile

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.